Implant with improved bone contact

Abstract
An intervertebral implant includes a body formed as an open lattice structure by a plurality of struts. Some of the struts of the plurality of struts intersect at nodes. The nodes can include an enlarged contact member that extends over the node and at least a portion of the width of some of the struts. Enlarged contact members may have an asymmetrical shape with respect to the intersection of struts. The enlarged contact members can provide improved bone contact for the implant. The plurality of struts can have a cross-sectional shape that includes a flattened portion. The flattened portion of the plurality of struts can provide improved bone contact for the implant. An additive manufacturing process can be used to build the implant in a substantially vertical direction.
Description
CROSS-REFERENCE TO RELATED APPLICATIONS

This application is a continuation of Sack, U.S. Pat. No. 10,744,001, issued Aug. 18, 2020, and titled “Implant with Improved Bone Contact,” the entire disclosure of which is hereby incorporated by reference.


BACKGROUND

The embodiments are generally directed to implants for supporting bone growth in a patient.


A variety of different implants are used in the body. Implants used in the body to stabilize an area and promote bone ingrowth provide both stability (i.e., minimal deformation under pressure over time) and space for bone ingrowth.


Spinal fusion, also known as spondylodesis or spondylosyndesis, is a surgical treatment method used for the treatment of various morbidities such as degenerative disc disease, spondylolisthesis (slippage of a vertebra), spinal stenosis, scoliosis, fracture, infection, or tumor. The aim of the spinal fusion procedure is to reduce instability and thus pain.


In preparation for the spinal fusion, most of the intervertebral disc is removed. An implant, the spinal fusion cage, may be placed between the vertebra to maintain spine alignment and disc height. The fusion, i.e., bone bridge, occurs between the endplates of the vertebrae.


SUMMARY

In one aspect, an intervertebral implant includes a body formed as an open lattice structure. The body includes a central core and an outer portion. The body also includes a contact surface and a perimeter surface. The contact surface is configured to confront a bone plate, the contact surface being spaced from the central core of the body. The contact surface can include a node, the node being an intersection of a first strut and a second strut. The first strut has a first longitudinal length and a first lateral width, the first longitudinal length being longer than the first lateral width. The second strut has a second longitudinal length and a second lateral width, the second longitudinal length being longer than the second lateral width. The node can include an enlarged contact member that extends between the first lateral width and the second lateral width.


In another aspect, an intervertebral implant includes a body formed as a lattice structure. The body includes a central core and an outer portion. The body also includes a superior surface, an inferior surface and a perimeter surface. The superior surface is configured to confront an upper bone plate. The superior surface is spaced from the central core of the body. The inferior surface is configured to confront a lower bone plate. The inferior surface is spaced from the central core of the body. The superior surface includes a node, the node being an intersection of a first strut and a second strut. The first strut has a first longitudinal length and a first lateral width, the first longitudinal length being longer than the first lateral width. The second strut has a second longitudinal length and a second lateral width, the second longitudinal length being longer than the second lateral width. The node can include an enlarged contact member that extends beyond the first lateral width and the second lateral width.


In another aspect, a method of making an intervertebral implant having a body is provided. The body includes a central core and an outer portion. The outer portion includes a superior surface, an inferior surface, and a perimeter surface. The method includes the step of additively manufacturing a first layer. The first layer is proximate a base plate. The first layer forms a part of the perimeter surface. The method also includes a step of continuing to additively manufacture the perimeter surface. The method also includes a step of additively manufacturing the superior surface and the inferior surface, wherein the superior surface extends away from the base plate, and wherein the inferior surface extends away from the base plate.


Other systems, methods, features, and advantages of the embodiments will be, or will become, apparent to one of ordinary skill in the art upon examination of the following figures and detailed description. It is intended that all such additional systems, methods, features, and advantages be included within this description and this summary, be within the scope of the embodiments, and be protected by the following claims.





BRIEF DESCRIPTION OF THE DRAWINGS

The embodiments can be better understood with reference to the following drawings and description. The components in the figures are not necessarily to scale, emphasis instead being placed upon illustrating the principles of the embodiments. Moreover, in the figures, like reference numerals designate corresponding parts throughout the different views.



FIG. 1 is a schematic isometric view of a step of implanting a device into a spinal column, according to an embodiment;



FIG. 2 is a schematic isometric view of a device implanted within a spinal column, according to an embodiment;



FIG. 3 is a schematic isometric view of an embodiment of an implant;



FIG. 4 is a schematic isometric view of an embodiment of an implant;



FIG. 5 is a schematic isometric view of an embodiment of an implant configured for improved bone contact;



FIG. 6 is an enlarged top view of the implant of FIG. 5, in which a single enlarged contact member is shown;



FIG. 7 is a schematic bottom view of the enlarged contact member shown in FIG. 6;



FIG. 8 is a cross-section view of the enlarged contact member shown in FIG. 7;



FIG. 9 is a schematic view of an alternate embodiment of an enlarged contact member for an implant;



FIG. 10 is a schematic view of another alternate embodiment of an enlarged contact member for an implant;



FIG. 11 is a schematic view of a prior art strut with a circular cross-sectional shape;



FIG. 12 is a schematic view of the prior art strut of FIG. 11 in contact with a bone;



FIG. 13 is a schematic isometric view of a strut with a flattened cross-sectional shape, according to an embodiment;



FIG. 14 is a schematic view of the strut of FIG. 13 in contact with a bone;



FIG. 15 is a schematic isometric view of a strut with a flattened cross-sectional shape, according to another embodiment;



FIG. 16 is a schematic view of the strut of FIG. 15 in contact with a bone;



FIG. 17 is a schematic view of a process of manufacturing an implant, according to an embodiment;



FIG. 18 is a side view of the implant of FIG. 17 during manufacture;



FIG. 19 is an enlarged view of an enlarged contact member of the implant of FIG. 17 during manufacture;



FIG. 20 is a side view of the enlarged contact member shown in FIG. 19;



FIG. 21 is a schematic lateral view of another implant; and



FIG. 22 is a schematic cross-sectional view of the implant shown in FIG. 21.





DETAILED DESCRIPTION

Any of the embodiments described herein may make use of any of the body/support structures, frames, plates, coils, or other structures disclosed in:

  • Hunt, U.S. Pat. No. 8,430,930, issued Apr. 30, 2013 and entitled “Truss Implant”;
  • Hunt, U.S. Patent Appl. Publ. No. 2011/0313532, published Dec. 22, 2011 and entitled “Bone Implant Interface System and Method”;
  • Hunt, U.S. Patent Appl. Publ. No. 2013/0030529, published Jan. 31, 2013 and entitled “Implant Interface system and method”;
  • Hunt et al., U.S. Patent Appl. Publ. No. 2013/0123935, published May 16, 2013 and entitled “Method of Length Preservation During Bone Repair”;
  • Hunt, U.S. Patent Appl. Publ. No. 2013/0218282, published Aug. 22, 2013 and entitled “Prosthetic Implant for Ball and Socket Joints and Method of Use”;
  • Hunt et al., U.S. Pat. No. 9,271,845, issued Mar. 1, 2016 and entitled “Programmable Implants and Methods of Using Programmable Implants to Repair Bone Structures”;
  • Hunt, U.S. Pat. No. 9,636,226, issued May 2, 2017 and entitled “Traumatic Bone Fracture Repair Systems and Methods”;
  • Hunt, U.S. Patent Appl. Publ. No. 2014/0288650, published Sep. 25, 2014 and entitled “Motion Preservation Implant and Methods”; and
  • Sack, U.S. Patent Appl. Publ. No. 2019/0151113, published May 23, 2019, and entitled “Implant with Improved Flow Characteristics.”


The entire disclosures of the patents and publications listed above are incorporated herein by reference in their entirety.


Implantation



FIG. 1 is a schematic view of an embodiment of an implant 100. For purposes of context, implant 100 is shown adjacent to a portion of a spinal column 101. In FIG. 2, an embodiment of implant 100 is shown following insertion between two adjacent vertebrae (vertebra 192 and vertebra 194) within spinal column 101. This insertion is facilitated by use of an insertion tool 105, which is shown schematically in FIGS. 1 and 2.


For purposes of this disclosure, implant 100 may also be referred to as a cage or fusion device. In some embodiments, implant 100 is configured to be implanted within a portion of the human body. In some embodiments, implant 100 may be configured for implantation into the spine. In some embodiments, implant 100 may be a spinal fusion implant, or spinal fusion device, which is inserted between adjacent vertebrae to provide support and/or facilitate fusion between the vertebrae.


In some embodiments, implant 100 may be inserted using an anterior lumbar interbody fusion (ALIF) surgical procedure, where the disc space is fused by approaching the spine through the abdomen. In the ALIF approach, a three-inch to five-inch incision is typically made near the abdomen and the abdominal muscles are retracted to the side. In some cases, implant 100 can be inserted through a small incision in the front or anterior side of the body. In some cases, an anterior approach may afford improved exposure to the disc space to a surgeon. The anterior approach can allow a larger device to be used for the fusion, increasing the surface area for fusion to occur and allowing for more postoperative stability. An anterior approach often makes it possible to reduce some of the deformity caused by various conditions, such as isthmic spondylolisthesis. Insertion and placement of the disc along the front of a human body can also re-establish the patient's normal sagittal alignment in some cases, giving individuals a more normal inward curve to their low back.


Introduction to Implant


For purposes of clarity, reference is made to various directional adjectives throughout the detailed description and in the claims. As used herein, the term “anterior” refers to a side or portion of an implant that is intended to be oriented toward the front of the human body when the implant has been placed in the body. Likewise, the term “posterior” refers to a side or portion of an implant that is intended to be oriented toward the back of the human body following implantation. In addition, the term “superior refers” to a side or portion of an implant that is intended to be oriented toward a top (e.g., the head) of the body while “inferior” refers to a side or portion of an implant that is intended to be oriented toward a bottom of the body. Reference is also made herein to “lateral” sides or portions of an implant, which are sides or portions facing along lateral directions of the body following implantation.



FIGS. 3-4 illustrate isometric views of an embodiment of implant 100. Specifically, FIG. 3 is a posterior isometric view while FIG. 4 is an anterior isometric view. In FIGS. 3-4, implant 100 is understood to be configured with an anterior side 110 and a posterior side 112. Implant 100 may also include a first lateral side 114 and a second lateral side 116 that extend between posterior side 112 and anterior side 110 on opposing sides of implant 100. Furthermore, implant 100 may also include a superior side 130 and an inferior side 140.


Implant 100 may also be associated with various edges that are located at the intersections between various sides. For example, superior side 130 and first lateral side 114 may meet at a superior-lateral edge. Likewise, inferior side 140 and first lateral side 114 may meet at an inferior-lateral edge. It may be appreciated that the term “edge” as used herein is not limited to a precise contour of implant 100 and is used instead to refer to a general region proximate the intersection of two sides or faces of implant 100.


Reference is also made to directions or axes that are relative to the implant itself, rather than to its intended orientation with regards to the body. For example, the term “central” refers to a part that is located closer to the center of the implant. As used herein, the “center of the implant” is generally defined as a vertical axis extending through the approximate middle of the implant, which may be approximately the location of the center of mass or the dimensional middle (i.e., equidistant from opposing sides.


An implant may also be associated with various axes. Referring to FIG. 3, implant 100 may be associated with a lateral axis 111 that extends along implant 100 between first lateral side 114 and second lateral side 116. Additionally, implant 100 may be associated with a posterior-anterior axis 113 that extends between posterior side 112 and anterior side 110. Moreover, implant 100 may be associated with a vertical axis 115 (which may also be referred to as a superior-inferior axis) that extends along the thickness dimension of implant 100 and which is generally perpendicular to both lateral axis 111 and posterior-anterior axis 113.


An implant may also be associated with various reference planes or surfaces. As used herein, the term “median plane” refers to a vertical plane that passes from the anterior side to the posterior side of the implant, dividing the implant into right and left halves, or lateral halves. As used herein, the term “transverse plane” refers to a horizontal plane located in the center of the implant that divides the implant into superior and inferior halves. As used herein, the term “coronal plane” refers to a vertical plane located in the center of the implant that divides the implant into anterior and posterior halves. In some embodiments, the implant is symmetric about two planes, such as the transverse plane.


Implant 100 is comprised of one or more body members attached to one or more bone contacting elements. In the embodiments shown in FIGS. 3-4, implant 100 includes a first body member 120. First body member 120 generally comprises a block-like member forming a solid end or side for implant 100. In the exemplary embodiment, first body member 120 is disposed at an anterior end of implant 100. Alternatively, in other embodiments, implant 100 could comprise one or more body members on either of the lateral sides or on the posterior side of implant 100.


In different embodiments, the geometry of one or more body members could vary. In some embodiments, first body member 120 may comprise a solid structure including various connected faces. As seen in FIG. 4, first body member 120 includes exterior surface 121 that is further comprised of a first central face 150, an angled face 151, and a second central face 152.


Some embodiments can include one or more fastener-receiving provisions. In some embodiments, an implant can include one or more threaded cavities. In some embodiments, a threaded cavity can be configured to mate with a corresponding threaded tip on an implantation tool or device. In other embodiments, a threaded cavity can receive a fastener for purposes of fastening an implant to another device or component in an implantation system that uses multiple implants and/or multiple components.


As best seen in FIG. 4, implant 100 includes a threaded cavity 170 disposed in first body member 120. In some embodiments, threaded cavity 170 may receive the threaded tip of an implantation tool (not shown). Such a tool could be used to drive implant 100 between adjacent vertebral bodies.


In some embodiments, one or more bone contacting elements may extend from first body member 120. In the embodiment shown in FIGS. 3-4, implant 100 includes a plurality of bone contacting elements 200 that may be attached, and/or continuously formed (or “integrally formed”) with, first body member 120.


As used herein, each bone contacting element comprises a distinctive member or element that spans a region or area of an implant. In some embodiments, these elements may overlap or intersect, similar to elements in a lattice or other 3D mesh structure. In other embodiments, the elements may not overlap or intersect. Some embodiments may use elongated elements, in which the length of the element is greater than its width and its thickness. For example, in embodiments where an element has an approximately circular cross-sectional shape, the element has a length greater than its diameter. In the embodiments seen in FIGS. 3-4, each bone contacting element is seen to have an approximately rounded or circular cross-sectional shape (i.e., the element has the geometry of a solid tube) along at least a portion of the element. However, in other embodiments, an element could have any other cross-sectional shape, including, but not limited to, various polygonal cross-sectional shapes (e.g., triangular, rectangular, etc.), as well as any other regular and/or irregular cross-sectional shapes. Examples of embodiments including a bone contacting element with a flattened cross-sectional shape are shown in FIGS. 13-16 and discussed in further detail below. In some cases, for example, the cross-sectional shape of a bone contacting element could vary along its length (e.g., the diameter could change along its length).


Geometry of Bone Contacting Elements


Embodiments can include provisions for protecting bone growth along and adjacent to bone contacting elements of an implant. In some embodiments, a bone contacting element can be configured with a geometry that helps to protect new bone growth in selected regions that may be referred to as “protected fusion zones.” In a protected fusion zone, new bone growth may be partially protected from forces transmitted directly between vertebrae and bone contacting surfaces of an implant, thereby increasing the rate at which new bone growth may propagate through the implant.


In some embodiments, a bone contacting element can have a spiral, helical, or twisted geometry that provide a series of such protected fusion zones for enhanced bone growth. In other embodiments, a bone contacting element can have a planar undulating geometry (e.g., sinusoidal) that may also create protected fusion zones. In some embodiments, an implant may include bone contacting elements with a helical geometry and other bone contacting elements with a sinusoidal, or planar undulating geometry.


Some bone contacting elements may have a generalized helical geometry. As used herein, a “generalized helical geometry” or “spiraling geometry” refers to a geometry where a part (portion, member, etc.) winds, turns, twists, rotates, or is otherwise curved around a fixed path. In some cases, the fixed path could be straight. In other cases, the fixed path can be curved. In the present embodiments, for example, the fixed path is generally a combination of straight segments and curved segments.


Curves having a generalized helical geometry (also referred to as generalized helical curves) may be characterized by “coils,” “turns,” or “windings” about a fixed path. Exemplary parameters that may characterize the specific geometry of a generalized helical curve can include coil diameter (including both a major and minor diameter) and the pitch (i.e., spacing between adjacent coils). In some cases, the “amplitude” of a coil or loop may also be used to describe the diameter or widthwise dimension of the coil or loop. Each of these parameters could be constant or could vary over the length of a generalized helical curve.


Generalized helical curves need not be circular or even round. In some embodiments, for example, a generalized helical curve could have a linearly segmented shape (or locally polygonal shape) such that each “coil” or “turn” is comprised of straight line segments rather than arcs or other curved segments. Generalized helical curves may also include combinations of curved and straight segments.


For purposes of characterizing the geometry of one or more bone contacting elements, each bone contacting element can be identified with one or more curves. Each bone contacting element may be identified with a central curve. The central curve of each bone contacting element may be defined as a curve that extends along the length (or longest dimension) of the bone contacting element such that each point along the curve is centrally positioned within the bone contacting element. In addition, each bone contacting element may be identified with one or more exterior surface curves. An exterior surface curve of a bone contacting element may be defined as a curve that extends along the length (or longest dimension) of the bone contacting element such that each point along the curve is positioned on the exterior surface.


In some situations, the approximately rounded or circular cross-sectional shape of bone contacting elements may apply unwanted stress to bone in areas where the bone contacting elements of the implant are in direct contact with the bone. For example, particularly in the case of older patients and/or patients with osteoporosis or other conditions that result in brittle or fragile bones, the stress associated with the direct contact from the approximately rounded or circular cross-sectional shape of bone contacting elements of the implant can weaken or otherwise damage the bone in the proximity of the implant. Accordingly, in some embodiments, an implant may be provided with components that are configured for improved bone contact.



FIG. 5 is a schematic view of an exemplary embodiment of an implant 500 configured for improved bone contact. In this embodiment, implant 500 includes a body 502 formed as an open lattice structure made of a plurality of bone contacting elements or struts 510. Body 502 can include a central core 504 and an outer portion 506. Central core 504 is disposed approximately within the middle or center of body 502 of implant 500. Outer portion 506 is disposed outward from central core 504 and generally surrounds central core 504. Outer portion 506 extends from central core 504 to the perimeter edge of implant 500.


Plurality of struts 510 form the open lattice structure of body 502 of implant 500. Plurality of struts 510 are generally elongate members having a longitudinal length and a lateral width, with the longitudinal length being longer than the lateral width. Plurality of struts 510 can include one or more outer struts 512 and one or more inner struts 514. In this embodiment, outer struts 512 are disposed along the perimeter edge of implant 500 and define the boundary of outer portion 506. Outer struts 512 can include substantially straight segments and/or curved or arched segments. In some embodiments, outer struts 512 may include combinations of curved and straight segments that assist with providing and defining the overall shape of implant 500.


Inner struts 514 extend from the perimeter edge of implant 500 defined by outer struts 512 inward toward central core 504 of body 502. Inner struts 514 intersect with one another at one or more nodes 520. A plurality of inner struts 514 intersects at a plurality of nodes 520 to collectively form the open lattice structure of body 502. In this embodiment, inner struts 514 are substantially straight segments. In other embodiments, inner struts 514 can include substantially straight segments, curved or arched segments, and/or a combination of curved and straight segments to form an open lattice structure.


Body 502 of implant 500 further includes a contact surface and a perimeter surface. The contact surface is configured to confront a bone plate when implant 500 is implanted into a patient. In this embodiment, the contact surface is spaced apart from central core 504 of body 502. In various embodiments, the contact surface can be a superior surface configured to confront an upper bone plate and/or an inferior surface configured to confront a lower bone plate. In some embodiments, an implant may include a superior contact surface, an inferior contact surface, or both.


The perimeter surface of body 502 of implant 500 is disposed approximately orthogonal to the contact surface or contact surfaces of implant 500 and extends substantially circumferentially around the perimeter edge of outer portion 506 of implant 500. Generally, the perimeter surface of body 502 is not configured to confront a bone plate when implant 500 is implanted into a patient.


In some embodiments, outer portion 506 of body 502 can include one or more screw plates 530. Screw plates 530 may include components configured to assist insertion and placement of implant 500 within a patient. In this embodiment, the outer surface of screw plates 530 is substantially planar with the remaining perimeter surface of body 502. In other embodiments, portions of screw plates 530 can extend beyond the perimeter surface of body 502 of implant 500.


In some embodiments, the contact surface of an implant can include components configured for improved bone contact. In an exemplary embodiment, superior and/or inferior contact surfaces of body 502 of implant 500 include one or more enlarged contact members 540. Enlarged contact members 540 can be disposed at various locations on the contact surfaces of body 502 of implant 500. In this embodiment, enlarged contact members 540 are located at one or more of plurality of nodes 520 where two or more of plurality of struts 510 intersect with each other. Additional enlarged contact members 540 can be disposed at other nodes of intersection between two or more of plurality of struts 510, including outer struts 512, inner struts 514, and/or a combination of both across various portions of the contact surfaces of implant 500.



FIG. 6 illustrates an enlarged view of an exemplary embodiment of an enlarged contact member 540. In an exemplary embodiment, enlarged contact member 540 is disposed at the node of an intersection between two or more of plurality of struts 510. In this embodiment, enlarged contact member 540 is disposed at the node of an intersection between five inner struts 514, including a first strut 610, a second strut 612, a third strut 614, a fourth strut 616, and a fifth strut 618. Enlarged contact member 540 includes a substantially flattened surface 600 that is configured to confront a bone plate of a patient. In some cases, flattened surface 600 of enlarged contact member 540 can be textured to assist with adhesion to the bone plate.


In an exemplary embodiment, enlarged contact member 540 has a generally ovoid or rounded shape defined by an outer perimeter edge 602. In this embodiment, outer perimeter edge 602 extends beyond the node of intersection between first strut 610, second strut 612, third strut 614, fourth strut 616, and fifth strut 618. In addition, enlarged contact member 540 also extends beyond the lateral width of each of first strut 610, second strut 612, third strut 614, fourth strut 616, and fifth strut 618. That is, enlarged contact member 540 is wider than each of the lateral widths of first strut 610, second strut 612, third strut 614, fourth strut 616, and fifth strut 618. Flattened surface 600 of enlarged contact member 540 provides a substantially greater surface area for confronting a bone plate than would be provided by the node of intersection of plurality of struts 510 and/or the lateral width of any of the individual struts themselves. With this arrangement, enlarged contact member 540 assists with providing improved bone contact to implant 500 and allows forces and/or stresses applied to the bone to be distributed across the larger surface area of flattened surface 600.


Referring now to FIG. 7, the underside or bottom view of enlarged contact member 540 shown in FIG. 6 is illustrated. In this embodiment, plurality of struts 510, in this case, plurality of inner struts 514, including first strut 610, second strut 612, third strut 614, fourth strut 616, and fifth strut 618, intersect at node 520. Enlarged contact member 540 extends over node 520 such that outer perimeter edge 602 is spaced outward from node 520. As can be seen in FIG. 7, enlarged contact member 540 also extends beyond the lateral width of each of first strut 610, second strut 612, third strut 614, fourth strut 616, and fifth strut 618.


In this embodiment, on the underside of enlarged contact member 540, first strut 610, second strut 612, third strut 614, fourth strut 616, and fifth strut 618 have a substantially rounded cross-sectional shape. As noted above, on the opposite side of enlarged contact member 540, flattened surface 600 is substantially flat and is configured to confront a bone plate of a patient.



FIG. 8 illustrates a cross section of a portion of enlarged contact member 540 taken along the line shown in FIG. 7. The cross-sectional view of the portion of enlarged contact member 540 shows substantially flattened surface 600 on one side of enlarged contact member 540 and the substantially rounded cross-sectional shape of first strut 610 on the opposite side. In this embodiment, substantially flattened surface 600 is oriented on implant 500 to face outward from central core 504 of implant. With this arrangement, one or more flattened surfaces 600 of a plurality of enlarged contact members 540 can be configured to provide superior and/or inferior contact surfaces of body 502 of implant 500.


In one embodiment, the shape of enlarged contact member 540 may be asymmetrical with respect to the intersection of two or more struts of plurality of struts 510. That is, a portion of enlarged contact member 540 that extends in one direction from a node of intersection between two or more struts of plurality of struts 510 may have a different shape and/or size than another portion of enlarged contact member 540 that extends in a different direction from the node of intersection. For example, FIGS. 9 and 10, described in more detail below, illustrate two alternate embodiments of an enlarged contact member having a generally asymmetrical shape with respect to the intersection of two or more struts of a plurality of struts.


Referring now to FIG. 9, an underside bottom view of an alternate embodiment of an asymmetric enlarged contact member 930 is illustrated. In this embodiment, a plurality of struts, including a first strut 910, a second strut 912, and a third strut 914, intersect at a node 920. Asymmetric enlarged contact member 930 extends over node 920 such that an outer perimeter edge 932 of asymmetric enlarged contact member 930 is spaced outward from node 920. Asymmetric enlarged contact member 930 also extends over the lateral width of portions of each of first strut 910, second strut 912, and third strut 914. In this embodiment, the shape of asymmetric enlarged contact member 930 is asymmetric with respect to the intersection of at least two struts of first strut 910, second strut 912, and/or third strut 914.


For example, as shown in FIG. 9, asymmetric enlarged contact member 930 includes three areas disposed between the intersection of adjacent struts, including a first area 934 disposed between the intersection of first strut 910 and second strut 912, a second area 936 disposed between the intersection of first strut 910 and third strut 914, and a third area 938 disposed between the intersection of second strut 912 and third strut 914. In this example, first area 934 is larger than either or both of second area 936 and third area 938.


Asymmetric enlarged contact member 930 is asymmetrically disposed with respect to the intersection of at least two struts of first strut 910, second strut 912, and/or third strut 914 such that first area 934 is asymmetric with second area 936 and third area 938 with respect to the intersection of first strut 910 and second strut 912, second area 936 is asymmetric with first area 934 and third area 938 with respect to the intersection of second strut 912 and third strut 914, and third area 938 is asymmetric with first area 934 and second area 936 with respect to the intersection of first strut 910 and third strut 914. With this arrangement, asymmetric enlarged contact member 930 may provide a larger surface area for a contact surface of an implant in a particular location on the implant.


In an exemplary embodiment, asymmetric enlarged contact member 930 may have an approximately teardrop or pear shape. The teardrop or pear shape of asymmetric enlarged contact member 930 shown in FIG. 9 has a wider width at one end and a narrower width at the opposite end. For example, asymmetric enlarged contact member 930 is wider at one end located in first area 934 and is narrower at the opposite end located in second area 936 and/or third area 938. With this configuration, outer perimeter edge 932 of asymmetric enlarged contact member 930 defines a teardrop or pear shape.


Referring now to FIG. 10, another alternate embodiment of an asymmetric enlarged contact member 1030 is illustrated from a bottom view. In this embodiment, a plurality of struts, including a first strut 1010, a second strut 1012, a third strut 1014, and a fourth strut 1016 intersect at a node 1020. Asymmetric enlarged contact member 1030 extends away from node 1020 such that an outer perimeter edge 1032 of asymmetric enlarged contact member 1030 is spaced outward from node 1020. Asymmetric enlarged contact member 1030 also extends over the lateral width of portions of first strut 1010, second strut 1012, and third strut 1014. In this embodiment, asymmetric enlarged contact member 1030 does not extend in the opposite direction over node 1020 and does not extend over any portion of the lateral width of fourth strut 1016. In this embodiment, the shape of asymmetric enlarged contact member 930 is asymmetric with respect to the intersection of at least two struts of first strut 1010, second strut 1012, and/or third strut 1014.


For example, as shown in FIG. 10, asymmetric enlarged contact member 1030 includes two areas disposed between the intersection of adjacent struts, including a first area 1034 disposed between the intersection of first strut 1010 and second strut 1012 and a second area 1036 disposed between the intersection of second strut 1012 and third strut 1014. In contrast with the embodiment of FIG. 9, in this embodiment, asymmetric enlarged contact member 1030 is absent between the intersection between third strut 1014 and fourth strut 1016. In this embodiment, asymmetric enlarged contact member 1030 also is absent between the intersection between first strut 1010 and fourth strut 1016.


Asymmetric enlarged contact member 1030 is asymmetrically disposed with respect to the intersection of at least two struts of first strut 1010, second strut 1012, third strut 1014, and/or fourth strut 1016 such that first area 1034 or second area 1036 is asymmetric with respect to the intersection of first strut 1010, second strut 1012, third strut 1014, and fourth strut 1016 at node 1020. As shown in FIG. 10, first area 1034 and second area 1036 of asymmetric enlarged contact member 1030 extend outward from node 1020 in one direction, while asymmetric enlarged contact member 1030 is absent in the opposite direction from node 1020. With this arrangement, asymmetric enlarged contact member 1030 may provide a larger surface area for a contact surface of an implant in a particular location and/or direction on the implant.


In an exemplary embodiment, asymmetric enlarged contact member 1030 may have an approximately semi-circular or partially rounded shape. The semi-circular or partially rounded shape of asymmetric enlarged contact member 1030 shown in FIG. 10 fans outward in an approximately radial direction from node 1020 such that outer perimeter edge 1032 defines the semi-circular or partially rounded shape. In this embodiment, asymmetric enlarged contact member 1030 extends away from first strut 1010 and third strut 1014 in one direction from node 1020 so as to define an approximately fan-shaped semi-circular shape.


With regard to the shapes of enlarged contact members shown in the previous embodiments, including the shapes shown in FIGS. 5 through 10 described above, it should be understood that other shapes may also be provided, including, but not limited to, geometric and non-geometric or irregular shapes.



FIGS. 5 through 10 illustrate embodiments of an exemplary enlarged contact member. It should be understood that an implant can include any number of enlarged contact members with substantially similar configurations, as well as a combination of different configurations according to the previous embodiments. Implants according to the embodiments described herein may include enlarged contact members that are disposed at various nodes of intersection between two or more struts of a plurality of struts, including outer struts, inner struts, and/or a combination of both across various portions of the contact surfaces of the implant. With this configuration, an implant can be configured with enlarged contact members at selected locations across the contact surfaces of the implant as desired for a particular type or configuration of implant.


In some embodiments, an implant may be provided with bone contacting elements or struts that have a cross-sectional profile configured to assist with improved bone contact. As previously described, the approximately rounded or circular cross-sectional shape of bone contacting elements or struts may apply unwanted stress to bone in areas where the bone contacting elements of the implant are in direct contact with the bone. For example, FIGS. 11 and 12 illustrate an example of a prior art strut having an approximately rounded or circular cross-sectional shape.


As shown in FIG. 11, strut 1100 has an approximately rounded or circular cross-sectional shape 1102 and a cylindrical outer surface 1104. Strut 1100 is placed in contact with a bone, as shown in FIG. 12. Because of the rounded or circular cross-sectional shape 1102 of strut 1100, only a small portion of cylindrical outer surface 1104 is in direct contact with the outer surface of bone 1120. For example, in FIG. 12, contact area 1130 between cylindrical outer surface 1104 of strut 1100 and bone 1120 is a single point 1106, e.g., a tangent to rounded or circular cross-sectional shape 1102 of strut 1100, that forms a line extending along the length of strut 1100 in contact with bone 1120. Such a small contact area can place unwanted stress and force to bone 1120 along contact area 1130.



FIGS. 13 through 16 illustrate various embodiments of cross-sectional shapes for a strut of an implant that can assist with dissipating force and stress over a larger contact area with a bone of a patient.


Referring now to FIG. 13, an exemplary embodiment of a flattened strut 1300 has an inverted semi-circular dome shape 1302. In this embodiment, flattened strut 1300 includes a first portion having a rounded or semi-circular cross-sectional shape and a second portion having a generally flat shape. As shown in FIG. 13, flat surface 1304 of flattened strut 1300 is disposed along a top portion of flattened strut 1300 and semi-cylindrical outer surface 1306 extends from the top portion around the remaining portion of flattened strut 1300 to form the inverted semi-circular dome shape 1302.


Flat surface 1304 of flattened strut 1300 provides a larger surface area for contact with a bone of a patient. As shown in FIG. 14, flat surface 1304 of flattened strut 1300 is in direct contact with the outer surface of bone 1320 along contact area 1330. In this embodiment, contact area 1330 extends across the lateral width of flattened strut 1300 and corresponds with the area of flat surface 1304 on the top portion of flattened strut 1300. With this configuration, contact area 1330 of flattened strut 1300 is significantly larger than contact area 1130 provided by point 1106 in the prior art strut 1100, described above.


Referring now to FIG. 15, another exemplary embodiment of a flattened strut 1500 has an inverted bell shape 1502. In this embodiment, flattened strut 1500 includes a first portion having a rounded or semi-circular cross-sectional shape, two portions on either side of the first portion that flare outward to form a generally convex contour, and a third portion having a generally flat shape. As shown in FIG. 15, flat surface 1504 of flattened strut 1500 is disposed along a top portion of flattened strut 1500 and a semi-cylindrical outer surface extends from an opposite bottom portion and flares outward to form a generally convex contoured surface on either side of the bottom portion. The flared-out portions on the sides include a first wing 1506 and a second wing 1508 disposed on opposite sides of flat surface 1504. Together, the semi-cylindrical outer surface on the bottom portion, the flared first wing 1506 and flared second wing 1508, and flat surface 1504 on the top portion of flattened strut 1500 form the inverted bell shape 1502.


Flat surface 1504 of flattened strut 1500 provides a larger surface area for contact with a bone of a patient. As shown in FIG. 15, flat surface 1504 of flattened strut 1500 is in direct contact with the outer surface of bone 1520 along contact area 1530. In this embodiment, contact area 1530 extends across the lateral width of flattened strut 1500 and corresponds with the area of flat surface 1504 on the top portion of flattened strut 1500. With this configuration, contact area 1530 of flattened strut 1500 is significantly larger than contact area 1130 provided by point 1106 in the prior art strut 1100, described above. Additionally, because of flared first wing 1506 and flared second wing 1508, flat surface 1504 is also wider than flat surface 1304 of flattened strut 1300 to provide contact area 1530 of flattened strut 1500 that is larger than contact area 1330 of flattened strut 1300.


It should be understood that other configurations of cross-sectional shapes with flat surfaces for struts that are configured to provide an enlarged contact area with a bone of a patient are possible according to the principles described above with reference to FIGS. 13-16.


Manufacturing and Materials


The various components of an implant may be fabricated from biocompatible materials suitable for implantation in a human body, including, but not limited to, metals (e.g., titanium or other metals), synthetic polymers, ceramics, and/or their combinations, depending on the particular application and/or preference of a medical practitioner.


Generally, the implant can be formed from any suitable biocompatible, non-degradable material with sufficient strength. Typical materials include, but are not limited to, titanium, biocompatible titanium alloys (e.g. γTitanium Alum inides, Ti6—Al4—V ELI (ASTM F 136), or Ti6—Al4—V (ASTM F 1108 and ASTM F 1472)) and inert, biocompatible polymers, such as polyether ether ketone (PEEK) (e.g. PEEK-OPTIMA®, Invibio Inc). Optionally, the implant contains a radiopaque marker to facilitate visualization during imaging.


In different embodiments, processes for making an implant can vary. In some embodiments, the entire implant may be manufactured and assembled via injection-molding, cast or injection molding, insert-molding, co-extrusion, pultrusion, transfer molding, overmolding, compression molding, 3-Dimensional (3-D) printing, dip-coating, spray-coating, powder-coating, porous-coating, milling from a solid stock material, and their combinations.


Referring now to FIGS. 17 through 20, an exemplary process of manufacturing an implant with enlarged contact members, according to any of the previous embodiments is illustrated. In this exemplary process, an additive manufacturing technique, for example, 3-D printing, is used to manufacture an implant with enlarged contact members. According to the exemplary process, an implant, for example, implant 500, described above, is printed in a substantially vertical direction. That is, the implant is printed in a direction starting at one end along the perimeter surface of the implant and continuing to add layers until forming the opposite end of the perimeter surface. The exemplary process described here is in contrast to printing in a substantially horizontal direction, which would be in a direction starting at the contact surface on one side of the implant (e.g., the top or bottom of the implant) and continuing to add layers until forming the contact surface on the opposite side of the implant.


With the exemplary process, each of the inferior and superior contact surfaces on opposite sides of the implant are formed in a substantially vertical direction such that each successive layer adds material to both the inferior and superior contact surfaces on opposite sides of the implant during the same pass.


Referring now to FIG. 17, an implant 1700 is shown in a partially printed condition during an exemplary manufacturing process. In this embodiment, the exemplary manufacturing process is an additive manufacturing process, for example, a 3-D printing process, that builds up material layer by layer to form the implant. The exemplary manufacturing process begins by additively manufacturing a first layer 1704 proximate to a base plate 1702. Base plate 1702 is a platform or other component that is configured to provide a surface for building the implant during the exemplary manufacturing process. As discussed above, in this exemplary process, implant 1700 is built in a substantially vertical direction. In this case, first layer 1704 is a portion of a perimeter surface of implant 1700. That is, implant 1700 has a substantially similar configuration as implant 500, described above, with a central core surrounded by an outer portion, opposite contact surfaces spaced from the central core, and a perimeter surface disposed approximately orthogonal to the contact surfaces and extending around the perimeter of the outer portion. With this configuration, the substantially vertical direction of manufacturing with the exemplary process results in first layer 1704 being a portion of the perimeter surface at one end of implant 1700.


During the exemplary manufacturing process, additional layers 1720 of material are built up in the vertical direction by multiple passes, with each pass adding material to first layer 1704 and subsequent additional layers to continue to form implant 1700. As shown in FIG. 17, implant 1700 is in a partially manufactured condition with first layer 1704 proximate base plate 1702 and a plurality of struts 1710 extending away from first layer 1704. In this embodiment, plurality of struts 1710 includes outer struts, substantially similar to outer struts 512, described above. As additional layers are formed during the exemplary manufacturing process, additional struts can be manufactured, including additional outer struts, inner struts, substantially similar to inner struts 514, described above, or a combination of outer and inner struts to form a lattice structure of implant 1700.



FIG. 18 illustrates a side view of implant 1700 during the exemplary manufacturing process shown in FIG. 17. In this embodiment, first layer 1704 is shown proximate to base plate 1702 and plurality of struts 1710 are shown in partial formation extending away from base plate 1702. In addition, during the substantially vertical direction of manufacturing, the contact surfaces on opposite sides of implant 1700 are formed in layers such that material is added to both sides during the same pass of the additive manufacturing process.


For example, in FIG. 18, implant 1700 includes a first contact surface 1800 and a second contact surface 1802 disposed on the opposite side of implant 1700. In this case, first contact surface 1800 can be an inferior surface and second contact surface can be a superior surface. During the additive manufacturing process, each successive layer adds material to both first contact surface 1800 and second contact surface 1802 on opposite sides of implant 1700 during the same pass.


In some embodiments, enlarged contact members, which may be substantially similar to any of the previous embodiments of enlarged contact members described above, can also be made during the exemplary process of making implant 1700. FIG. 19 illustrates a close-up view of an exemplary enlarged contact member 1900 that is additively manufactured on one or more of inferior and superior contact surfaces at nodes of intersection between plurality of struts 1710. In this embodiment, enlarged contact member 1900 is formed at a node of intersection between a first strut 1910, a second strut 1912, a third strut 1914, and a fourth strut 1916. As seen in FIG. 20, enlarged contact member 1900 is oriented so that a flattened surface 1902 of enlarged contact member 1900 is configured to face outward on first contact surface 1800 of implant 1700. With this arrangement, flattened surface 1902 of enlarged contact member 1900 is configured to confront a bone of a patient.


In some embodiments, enlarged contact members can be manufactured such that one end that is closer to the base plate is narrower than the other end that is disposed further from base plate. As shown in FIG. 19, enlarged contact member 1900 includes a first end 1906 that is disposed closer to base plate 1702. During the exemplary manufacturing process, first end 1906 of enlarged contact member 1900 is formed first and successive layers build up additional material to form enlarged contact member 1900. In some cases, as successive layers build up enlarged contact member 1900, enlarged contact member 1900 may become wider than first end 1906.


As shown in FIG. 19, first end 1906 is narrower than a second end 1908 that is disposed further from base plate 1702. That is, second end 1908 of enlarged contact member 1900 has a larger width than first end 1906 of enlarged contact member 1900. With successive layers of additive manufacturing, enlarged contact member 1900 widens from first end 1906 to second end 1908. This exemplary process can provide an asymmetrical shape to enlarged contact member 1900, for example, any of the asymmetrical shapes described above with reference to FIGS. 9 and 10 above. In addition, first end 1906 having a smaller width than second end 1908 can provide a more secure attachment to plurality of struts 1710 and may also permit the width of enlarged contact member 1900 to increase gradually to the width at second end 1908 during the additive manufacturing process.


In addition, the additive manufacturing process described above can provide texture to flattened surface 1902 of enlarged contact member 1900. The addition of material in successive layers to form enlarged contact member 1900 can provide surface irregularities that serve as a textured surface for flattened surface 1902 of enlarged contact member 1900. With this arrangement, the textured flattened surface 1902 of enlarged contact member 1900 may assist with providing greater adhesion in contact with a bone of a patient.


Thus, in some cases, the implant may be formed by additive manufacturing (e.g., 3-D printing) in an anatomical orientation. That is, the implant may be formed from the bottom up in its regular upright position, as it would be positioned within the body of the patient. However, in other cases, the implant may be formed by an additive manufacturing process in a non-anatomical orientation. For example, in some cases, the implant may be formed on its side, as discussed above. For instance, in some cases, the implant may be formed beginning with the anterior surface and concluding with the posterior surface. In some cases, the implant may be formed beginning with one lateral side and concluding with the opposing lateral side.


Provisions may be used to facilitate additive manufacturing in one or more particular orientations. For example, in some cases, additive manufacturing may be facilitated by the orientations of the struts. For example, in the orientation in which the implant is desired to be manufactured, the roof angle, i.e., the angle between the underside of a structural component and a horizontal plane, may be 30 degrees or greater. In some embodiments, the minimum roof angle may be 32 degrees.


Alternatively, or additionally, thin, vertically oriented elements, may be printed with the implant, but knocked out after the printing is completed. Such knock-out or punch-out elements may be utilized anywhere in the implent to facilitate manufacturing. In some embodiments, closely-spaced, paper-thin vertical elements may be printed as a supportive base in order to additively manufacture structures with a roof angle of less than 30 degrees. With the vertical elements so closely spaced, there is a small enough span between the vertical elements that the horizontal structures can be added despite having a roof angle smaller than 30 degrees. Because the vertical elements are so thin, they can be easily broken away from the completed implant after the additive manufacturing process has been complete. That is, the vertical elements can be “knock-outs” or “punch-out” elements that are removed after manufacturing. In some embodiments, implants may be provided that include one or more features disclosed in Sack, U.S. Patent Application Publication No. 2019/0151113, published on May 23, 2019, and entitled “Implant with Improved Flow Characteristics.”



FIG. 21 is a lateral view of implant 2600 when oriented standing on an anterior side 2615 as it would be during the manufacturing process illustrated in FIG. 26. Implant 2600 includes structural features having roof angles that are a minimum of 30 degrees. As shown in FIG. 21, implant 2600 also includes a posterior side 2620. Further, implant 2600 may also include a superior surface 2640 and an inferior surface 2645. As shown in FIG. 21, implant 2600 may include a plurality of peripheral struts around the perimeter of implant 2600 that are arranged in X-shaped configurations. As shown in FIG. 21, first peripheral strut 2650 has a roof angle 2655. In some embodiments, roof angle 2655 may be 30 degrees or greater. For example, in some cases, roof angle 2655 may be approximately 32 degrees. In some embodiments, each of the peripheral struts may have roof angles of 30 degrees or greater. In some cases, the minimum roof angle of the peripheral struts may be approximately 32 degrees.


In addition, as also shown in FIG. 21, posterior structures extending in the superior-inferior direction, such as a posterior structure 2660, may have roof angles of 30 degrees or more. Posterior structure 2660 may have a first anterior-facing surface 2665 and a second anterior-facing surface 2670. As shown in FIG. 21, first anterior-facing surface 2665 and second anterior-facing surface 2670 may both have roof angles of 30 degrees or more. For example, in some cases, all structural elements extending in the superior-inferior direction may have a minimum roof angle of 30 degrees or more. For instance, the minimum roof angle may be approximately 32 degrees.


It will also be understood that, in addition to the peripheral structures, the internal structures of implant 2600 may also have minimum roof angles of 30 degrees or more. For example, as shown in FIG. 22, an internal strut 2675 may have a roof angle 2680. In some embodiments, roof angle 2680 may be 30 degrees or greater. For example, in some cases, roof angle 2680 may be approximately 32 degrees.


In addition, internal posterior structures, such as a posterior structure 2685, may have roof angles of 30 degrees or more. Posterior structure 2685 may have a first anterior-facing surface 2690 and a second anterior-facing surface 2695. As shown in FIG. 22, first anterior-facing surface 2690 and second anterior-facing surface 2695 may both have roof angles of 30 degrees or more. For example, in some cases, all structural elements extending in the superior-inferior direction may have a minimum roof angle of 30 degrees or more. For instance, the minimum roof angle may be approximately 32 degrees.


While various embodiments have been described, the description is intended to be exemplary, rather than limiting, and it will be apparent to those of ordinary skill in the art that many more embodiments and implementations are possible that are within the scope of the embodiments. Although many possible combinations of features are shown in the accompanying figures and discussed in this detailed description, many other combinations of the disclosed features are possible. Any feature of any embodiment may be used in combination with or substituted for any other feature or element in any other embodiment unless specifically restricted. Therefore, it will be understood that any of the features shown and/or discussed in the present disclosure may be implemented together in any suitable combination. Accordingly, the embodiments are not to be restricted except in light of the attached claims and their equivalents. Also, various modifications and changes may be made within the scope of the attached claims.

Claims
  • 1. An intervertebral implant comprising: a body formed as an open lattice structure, the body including a central core and an outer portion;the body including a contact surface and a perimeter surface;the contact surface configured to confront a bone plate, the contact surface being spaced from the central core of the body;the contact surface including a node defined by an intersection of a first strut and a second strut;the first strut having a first longitudinal length and a first lateral width, the first longitudinal length being longer than the first lateral width;the second strut having a second longitudinal length and a second lateral width, the second longitudinal length being longer than the second lateral width;wherein the implant includes an enlarged contact member disposed at the node defined by the intersection of the first strut and the second strut;wherein the enlarged contact member has a substantially flattened outer-facing surface forming part of the outer portion of the body;wherein the enlarged contact member has an outer perimeter edge that extends beyond the node defined by the intersection of the first strut and the second strut; andwherein at least a portion of the first strut and at least a portion of the second strut extend inward from the enlarged contact member toward the central core of the body.
  • 2. The intervertebral implant according to claim 1, wherein the contact surface is a superior surface configured to confront an upper bone plate.
  • 3. The intervertebral implant according to claim 1, wherein the contact surface is an inferior surface configured to confront a lower bone plate.
  • 4. The intervertebral implant according to claim 1, wherein the enlarged contact member is asymmetrically disposed with respect to the intersection of the first strut and the second strut.
  • 5. The intervertebral implant according to claim 1, wherein at least one of the first strut and the second strut includes a curved arch portion.
  • 6. The intervertebral implant according to claim 1, wherein at least one of the first strut and the second strut has a flattened cross-sectional shape.
  • 7. An intervertebral implant comprising: a body formed as a lattice structure, the body including a central core and an outer portion;the body including a superior surface, an inferior surface and a perimeter surface;the superior surface configured to confront an upper bone plate, the superior surface being spaced from the central core of the body;the inferior surface configured to confront a lower bone plate, the inferior surface being spaced from the central core of the body;the superior surface including a node defined by an intersection of a first strut and a second strut;the first strut having a first longitudinal length and a first lateral width, the first longitudinal length being longer than the first lateral width;the second strut having a second longitudinal length and a second lateral width, the second longitudinal length being longer than the second lateral width;wherein the implant includes an enlarged contact member disposed at the node defined by the intersection of the first strut and the second strut;wherein the enlarged contact member has a substantially flattened outer-facing surface forming part of the outer portion of the body;wherein the enlarged contact member has an outer perimeter edge that extends beyond the node defined by the intersection of the first strut and the second strut;wherein at least a portion of the first strut and at least a portion of the second strut extend inward from the enlarged contact member toward the central core of the body; andwherein the enlarged contact member is asymmetrically disposed with respect to the intersection of the first strut and the second strut.
  • 8. The intervertebral implant according to claim 7, wherein at least one of the first strut and the second strut includes a curved arch portion.
  • 9. The intervertebral implant according to claim 7, wherein the substantially flattened surface is oriented along one of the superior surface and the inferior surface of the intervertebral implant.
  • 10. The intervertebral implant according to claim 9, wherein the substantially flattened surface is textured.
  • 11. The intervertebral implant according to claim 7, further comprising a plurality of enlarged contact members on at least one of the superior surface and the inferior surface of the intervertebral implant.
  • 12. The intervertebral implant according to claim 7, wherein at least one of the first strut and the second strut has a flattened cross-sectional shape.
  • 13. The intervertebral implant according to claim 12, wherein the flattened cross-sectional shape of the at least one of the first strut and the second strut is oriented along one of the superior surface and the inferior surface of the intervertebral implant.
  • 14. An intervertebral implant comprising: a body formed as an open lattice structure, the body including a central core and an outer portion;the body including a contact surface and a perimeter surface;the contact surface configured to confront a bone plate, the contact surface being spaced from the central core of the body;the implant including a node defined by an intersection of a first strut and a second strut;the first strut having a first longitudinal length and a first lateral width, the first longitudinal length being longer than the first lateral width;the second strut having a second longitudinal length and a second lateral width, the second longitudinal length being longer than the second lateral width;wherein the implant includes an enlarged contact member disposed at the node defined by the intersection of the first strut and the second strut;wherein the enlarged contact member has a substantially flattened outer-facing surface forming part of the outer portion of the body;wherein the enlarged contact member has an outer perimeter edge that extends beyond the node defined by the intersection of the first strut and the second strut; andwherein at least one of the first strut and the second strut includes a curved arch portion.
  • 15. The intervertebral implant according to claim 14, wherein the contact surface is a superior surface configured to confront an upper bone plate.
  • 16. The intervertebral implant according to claim 14, wherein the contact surface is an inferior surface configured to confront a lower bone plate.
  • 17. The intervertebral implant according to claim 14, wherein the enlarged contact member is asymmetrically disposed with respect to the intersection of the first strut and the second strut.
  • 18. The intervertebral implant according to claim 14, wherein at least one of the first strut and the second strut has a flattened cross-sectional shape.
  • 19. The intervertebral implant according to claim 14, wherein at least a portion of the first strut and at least a portion of the second strut extend inward from the enlarged contact member toward the central core of the body.
US Referenced Citations (535)
Number Name Date Kind
3720959 Hahn Mar 1973 A
4038703 Bokros Aug 1977 A
4309777 Patil Jan 1982 A
4759769 Hedman Jul 1988 A
4851008 Johnson Jul 1989 A
4889685 Shimamune Dec 1989 A
4917704 Frey Apr 1990 A
4961740 Ray et al. Oct 1990 A
5055104 Ray Oct 1991 A
5198308 Shetty et al. Mar 1993 A
5263953 Bagby Nov 1993 A
5306310 Siebels Apr 1994 A
5397359 Mittelmeier Mar 1995 A
5423817 Lin Jun 1995 A
5458638 Kuslich et al. Oct 1995 A
5571192 Schonhoffer Nov 1996 A
5607424 Tropiano Mar 1997 A
5609635 Michelson Mar 1997 A
5609636 Kohrs Mar 1997 A
5658337 Kohrs et al. Aug 1997 A
5709683 Bagby Jan 1998 A
5716416 Lin Feb 1998 A
D403069 Drewry et al. Dec 1998 S
5885299 Winslow Mar 1999 A
5888223 Bray, Jr. Mar 1999 A
5897556 Drewry et al. Apr 1999 A
5954504 Misch et al. Sep 1999 A
5968098 Winslow Oct 1999 A
5973222 Devanathan et al. Oct 1999 A
6010502 Bagby Jan 2000 A
6039762 McKay Mar 2000 A
6090143 Meriwether et al. Jul 2000 A
6102948 Brosnahan, III Aug 2000 A
6126689 Brett Oct 2000 A
6149651 Drewry et al. Nov 2000 A
6156037 LeHuec et al. Dec 2000 A
6200348 Biedermann et al. Mar 2001 B1
6206924 Timm Mar 2001 B1
6210412 Michelson Apr 2001 B1
6371987 Weiland et al. Apr 2002 B1
6428575 Koo Aug 2002 B2
6436141 Castro et al. Aug 2002 B2
6464727 Sharkey Oct 2002 B1
6468309 Lieberman Oct 2002 B1
6494883 Ferree Dec 2002 B1
6500205 Michelson Dec 2002 B1
6520996 Manasas et al. Feb 2003 B1
6527805 Studer et al. Mar 2003 B2
6530956 Mansmann Mar 2003 B1
6537320 Michelson Mar 2003 B1
6558423 Michelson May 2003 B1
6569201 Moumene May 2003 B2
6582431 Ray Jun 2003 B1
6582467 Teitelbaum et al. Jun 2003 B1
6585770 White et al. Jul 2003 B1
6616695 Crozet et al. Sep 2003 B1
6666888 Jackson Dec 2003 B1
6709458 Michelson Mar 2004 B2
6758849 Michelson Jul 2004 B1
6808537 Michelson Oct 2004 B2
6846327 Khandkar et al. Jan 2005 B2
6849093 Michelson Feb 2005 B2
6863689 Ralph et al. Mar 2005 B2
6923810 Michelson Aug 2005 B1
6962606 Michelson Nov 2005 B2
6997953 Chung et al. Feb 2006 B2
7135043 Nakahara et al. Nov 2006 B2
7141068 Ross et al. Nov 2006 B2
7153325 Kim et al. Dec 2006 B2
7186267 Aston et al. Mar 2007 B2
7241313 Unwin et al. Jul 2007 B2
7261739 Ralph Aug 2007 B2
7297162 Mujwid Nov 2007 B2
7341601 Eisermann et al. Mar 2008 B2
7410501 Michelson Aug 2008 B2
7429270 Baumgartner et al. Sep 2008 B2
7435261 Castro Oct 2008 B1
7452369 Barry Nov 2008 B2
7465318 Sennett Dec 2008 B2
7485134 Simonson Feb 2009 B2
7527649 Blain May 2009 B1
7534254 Michelson May 2009 B1
7537603 Huebner et al. May 2009 B2
7537616 Branch et al. May 2009 B1
7575598 Albert Aug 2009 B2
7611217 Shamoun et al. Nov 2009 B2
7621952 Truckai et al. Nov 2009 B2
7621953 Braddock, Jr. et al. Nov 2009 B2
7628814 Studer et al. Dec 2009 B2
7645475 Prewett Jan 2010 B2
7655043 Peterman et al. Feb 2010 B2
7794500 Felix Sep 2010 B2
7799056 Sankaran Sep 2010 B2
7803191 Biedermann et al. Sep 2010 B2
7815665 Jahng Oct 2010 B2
7846207 Lechmann et al. Dec 2010 B2
7875075 Schwab Jan 2011 B2
7879100 Denoziere Feb 2011 B2
7879103 Gertzman et al. Feb 2011 B2
7935149 Michelson May 2011 B2
8016887 Castro Sep 2011 B1
8021424 Beger et al. Sep 2011 B2
8021426 Segal et al. Sep 2011 B2
8062365 Schwab Nov 2011 B2
8092536 Ahrens et al. Jan 2012 B2
8142507 McGuckin, Jr. Mar 2012 B2
8152849 Biedermann et al. Apr 2012 B2
8182538 O'Neil et al. May 2012 B2
8226718 Castro Jul 2012 B2
8241363 Sommerich et al. Aug 2012 B2
8246683 Castro Aug 2012 B2
8252059 Overes et al. Aug 2012 B2
8298286 Trieu Oct 2012 B2
8303879 Bertele et al. Nov 2012 B2
8343224 Lynn Jan 2013 B2
8361149 Castro Jan 2013 B2
8366777 Matthis et al. Feb 2013 B2
8414654 Ganey Apr 2013 B1
8414820 Bertele et al. Apr 2013 B2
8430930 Hunt Apr 2013 B2
8435300 Messerli et al. May 2013 B2
8454700 Lemoine et al. Jun 2013 B2
8475533 Castro Jul 2013 B1
8551173 Lechmann et al. Oct 2013 B2
8556978 Schaller Oct 2013 B2
8568413 Mazur et al. Oct 2013 B2
8613769 Sears et al. Dec 2013 B2
8623090 Butler Jan 2014 B2
8673006 Castro Mar 2014 B2
8700198 Conway et al. Apr 2014 B2
8702808 Teoh et al. Apr 2014 B2
8709042 Greenhalgh et al. Apr 2014 B2
8728160 Globerman May 2014 B2
8740981 Tornier et al. Jun 2014 B2
8771357 Biedermann Jul 2014 B2
8771368 McKay Jul 2014 B2
8795362 Anderson et al. Aug 2014 B2
8801787 Schaller Aug 2014 B2
8808376 Schaller Aug 2014 B2
8808725 Altschuler et al. Aug 2014 B2
8840614 Mikhail et al. Sep 2014 B2
8864831 Lee et al. Oct 2014 B2
8894661 McDevitt Nov 2014 B2
8900310 Carlson Dec 2014 B2
8900312 McLean et al. Dec 2014 B2
8932356 Kraus Jan 2015 B2
8940050 Laurence Jan 2015 B2
8940052 Lechmann et al. Jan 2015 B2
8951300 Parrish Feb 2015 B2
8986383 Castro Mar 2015 B2
9011499 Kiester Apr 2015 B1
9039766 Fonte May 2015 B1
9060876 To Jun 2015 B1
9101491 Rodgers Aug 2015 B2
D739935 Blain et al. Sep 2015 S
9138301 Kita et al. Sep 2015 B2
9155819 Fonte et al. Oct 2015 B2
9186252 Leibinger Nov 2015 B2
9186257 Geisler et al. Nov 2015 B2
9220518 Neal et al. Dec 2015 B2
9237958 Duggal et al. Jan 2016 B2
9247970 Teisen Feb 2016 B2
9254199 Biedermann et al. Feb 2016 B2
9271765 Blain Mar 2016 B2
9271771 Mathieu et al. Mar 2016 B2
9271845 Hunt et al. Mar 2016 B2
9289308 Marino et al. Mar 2016 B2
9289312 Davenport et al. Mar 2016 B2
9295562 Lechmann et al. Mar 2016 B2
9364330 Lindsey et al. Jun 2016 B2
9402733 To et al. Aug 2016 B1
9408651 Sennett et al. Aug 2016 B2
9421108 Hunt Aug 2016 B2
9427328 Drochner Aug 2016 B2
9433510 Lechmann et al. Sep 2016 B2
9433511 Bagga et al. Sep 2016 B2
9439779 Zhang et al. Sep 2016 B2
9439948 Lin et al. Sep 2016 B2
9452056 Early et al. Sep 2016 B2
9452064 Trautwein et al. Sep 2016 B2
9456901 Jones et al. Oct 2016 B2
9456907 Castro Oct 2016 B1
9517095 Vaidya Dec 2016 B2
9522028 Warren et al. Dec 2016 B2
9526548 Asfora Dec 2016 B2
9545317 Hunt Jan 2017 B2
9549823 Hunt et al. Jan 2017 B2
9554914 Taylor et al. Jan 2017 B2
9561117 Lechmann et al. Feb 2017 B2
9566095 Lorio Feb 2017 B2
9566100 Asfora Feb 2017 B2
9572669 Hunt et al. Feb 2017 B2
9597197 Lechmann et al. Mar 2017 B2
9603613 Schoenefeld et al. Mar 2017 B2
9622880 Dunworth et al. Apr 2017 B2
9629727 Baynham Apr 2017 B2
9636226 Hunt May 2017 B2
9649200 Wickham May 2017 B2
9662128 Reiley May 2017 B2
9662157 Schneider et al. May 2017 B2
9662158 Reiley May 2017 B2
9662224 Weiman et al. May 2017 B2
9662226 Wickham May 2017 B2
9668781 Stark Jun 2017 B2
9675394 Reiley Jun 2017 B2
9700356 Donner et al. Jul 2017 B2
9744051 Biedermann et al. Aug 2017 B2
9757235 Hunt et al. Sep 2017 B2
9782270 Wickham Oct 2017 B2
9788967 Jo Oct 2017 B2
9814578 Gotfried Nov 2017 B1
9907670 DeRidder et al. Mar 2018 B2
9918849 Morris Mar 2018 B2
9931209 Gotfried Apr 2018 B2
9987051 Nunley et al. Jun 2018 B2
9987137 Hunt et al. Jun 2018 B2
9999516 Hunt Jun 2018 B2
10004546 Gotfried Jun 2018 B2
10016279 Castro Jul 2018 B1
10058433 Lechmann et al. Aug 2018 B2
10064737 Tsai Sep 2018 B2
10098754 Larsson Oct 2018 B2
10117746 Cordaro Nov 2018 B2
10143569 Weiman et al. Dec 2018 B2
10154913 Steinmann et al. Dec 2018 B2
10159580 Guizzardi et al. Dec 2018 B2
10182923 Willis et al. Jan 2019 B2
10194962 Schneider et al. Feb 2019 B2
10195524 DeRidder et al. Feb 2019 B2
10213317 Bishop et al. Feb 2019 B2
10226357 Ries Mar 2019 B2
10265189 Melkent et al. Apr 2019 B2
10271958 Schaufler et al. Apr 2019 B2
10278833 Howard et al. May 2019 B2
10278834 Howard et al. May 2019 B2
10357377 Nyahay et al. Jul 2019 B2
10368997 Jones et al. Aug 2019 B2
10369009 Joly et al. Aug 2019 B2
10413427 Trieu Sep 2019 B2
10433977 Lechmann et al. Oct 2019 B2
10433979 Morris et al. Oct 2019 B2
10449051 Hamzey et al. Oct 2019 B2
10449055 McJunkin Oct 2019 B2
10449058 Lechmann et al. Oct 2019 B2
10478312 McShane, III et al. Nov 2019 B2
10492921 McShane, III et al. Dec 2019 B2
10507118 Afzal Dec 2019 B2
10512549 Bishop et al. Dec 2019 B2
10517739 Ryan Dec 2019 B2
10524926 Jasinski Jan 2020 B2
10524927 Ryan Jan 2020 B2
10524929 Shoshtaev Jan 2020 B2
10525688 O'Neill et al. Jan 2020 B2
10531962 Petersheim et al. Jan 2020 B2
10537666 Paddock Jan 2020 B2
10555819 Miccio Feb 2020 B2
10561456 Cawley et al. Feb 2020 B2
10575965 Kim et al. Mar 2020 B2
10588755 Vogt et al. Mar 2020 B2
10617532 Mazur et al. Apr 2020 B2
10624760 Mirda et al. Apr 2020 B2
10660763 Wilson et al. May 2020 B2
10660764 Maglaras et al. May 2020 B2
10667924 Nyahay et al. Jun 2020 B2
10675158 Unger et al. Jun 2020 B2
10675385 Barbas et al. Jun 2020 B2
10682238 Petersheim et al. Jun 2020 B2
10695192 Bishop et al. Jun 2020 B2
10709570 Stauffer et al. Jul 2020 B2
10716678 Stampfli et al. Jul 2020 B2
10722378 Davis et al. Jul 2020 B2
10744001 Sack Aug 2020 B2
10744003 Ryan et al. Aug 2020 B2
10765530 Steinmann et al. Sep 2020 B2
10772732 Miller et al. Sep 2020 B1
10835388 Milz et al. Nov 2020 B2
10849756 Hunt et al. Dec 2020 B2
10856999 Bishop et al. Dec 2020 B2
10940019 Vishnubhotla et al. Mar 2021 B2
11065039 McCormack Jul 2021 B2
20010014826 Biedermann et al. Aug 2001 A1
20010032018 Castro Oct 2001 A1
20020052656 Michelson May 2002 A1
20020120334 Crozet Aug 2002 A1
20020123750 Eisermann Sep 2002 A1
20020183847 Lieberman Dec 2002 A1
20030003127 Brown et al. Jan 2003 A1
20030060825 Alfaro Mar 2003 A1
20030078660 Clifford et al. Apr 2003 A1
20030083746 Kuslich May 2003 A1
20030109928 Pasquet Jun 2003 A1
20030181913 Lieberman Sep 2003 A1
20030236571 Ralph Dec 2003 A1
20040059419 Michelson Mar 2004 A1
20040082953 Petit Apr 2004 A1
20040122518 Rhoda Jun 2004 A1
20040193270 DiMauro et al. Sep 2004 A1
20040210312 Neumann Oct 2004 A1
20040225361 Glenn et al. Nov 2004 A1
20050015154 Lindsey et al. Jan 2005 A1
20050027364 Kim Feb 2005 A1
20050143733 Petit Jun 2005 A1
20050177238 Khandkar et al. Aug 2005 A1
20050222681 Richley Oct 2005 A1
20050278027 Hyde, Jr. Dec 2005 A1
20050278028 Mujwid Dec 2005 A1
20060041262 Calvert et al. Feb 2006 A1
20060052872 Studer Mar 2006 A1
20060052873 Buck Mar 2006 A1
20060058881 Trieu Mar 2006 A1
20060100706 Shadduck et al. May 2006 A1
20060147332 Jones Jul 2006 A1
20060212118 Abernathie Sep 2006 A1
20060217806 Peterman Sep 2006 A1
20060293753 Thramann Dec 2006 A1
20070027544 McCord et al. Feb 2007 A1
20070179610 Biedermann et al. Aug 2007 A1
20070198090 Abdou Aug 2007 A1
20070260324 Joshi et al. Nov 2007 A1
20080071356 Greenhalgh Mar 2008 A1
20080167686 Trieu Jul 2008 A1
20080183204 Greenhalgh Jul 2008 A1
20080255666 Fisher Oct 2008 A1
20080300602 Schmitt et al. Dec 2008 A1
20080306595 McLeod et al. Dec 2008 A1
20080312742 Abernathie Dec 2008 A1
20090030520 Biedermann Jan 2009 A1
20090036985 Whiting Feb 2009 A1
20090048678 Saal et al. Feb 2009 A1
20090048675 Bhatnagar et al. Mar 2009 A1
20090062917 Foley et al. Mar 2009 A1
20090112321 Kitchen Apr 2009 A1
20090149958 Prewett et al. Jun 2009 A1
20090248162 Peckham Oct 2009 A1
20100016974 Janowski Jan 2010 A1
20100036498 McDevitt Feb 2010 A1
20100057216 Gannoe et al. Mar 2010 A1
20100137990 Apatsidis Jun 2010 A1
20100152856 Overes Jun 2010 A1
20100161061 Hunt Jun 2010 A1
20100185292 Hochschuler Jul 2010 A1
20100228299 Zrinski et al. Sep 2010 A1
20100286778 Eisermann et al. Nov 2010 A1
20110015741 Melkent et al. Jan 2011 A1
20110029085 Hynes Feb 2011 A1
20110035019 Goswami et al. Feb 2011 A1
20110066192 Frasier et al. Mar 2011 A1
20110166660 Laurence Jul 2011 A1
20110190888 Bertele Aug 2011 A1
20110190895 Segal et al. Aug 2011 A1
20110208311 Janowski Aug 2011 A1
20110230970 Lynn Sep 2011 A1
20110245926 Kitchen Oct 2011 A1
20110270401 McKay Nov 2011 A1
20110301709 Kraus et al. Dec 2011 A1
20110313528 Laubert Dec 2011 A1
20110313532 Hunt Dec 2011 A1
20120010472 Spann Jan 2012 A1
20120010717 Spann Jan 2012 A1
20120150300 Nihalani Jun 2012 A1
20120158143 Shapiro Jun 2012 A1
20120191188 Huang Jul 2012 A1
20120191189 Huang Jul 2012 A1
20120239150 Ullrich Sep 2012 A1
20120296431 Kim Nov 2012 A1
20130021288 Kaerkkaeinen et al. Jan 2013 A1
20130030529 Hunt Jan 2013 A1
20130096685 Ciupik Apr 2013 A1
20130116793 Kloss May 2013 A1
20130123935 Hunt et al. May 2013 A1
20130158672 Hunt Jun 2013 A1
20130184826 Thaiyananthan Jul 2013 A1
20130190880 Schaller Jul 2013 A1
20130218288 Fonte Aug 2013 A1
20130226300 Chataigner Aug 2013 A1
20130304211 Trautwein et al. Nov 2013 A1
20140018814 Gillard et al. Jan 2014 A1
20140052260 McKenny Feb 2014 A1
20140058513 Gahman et al. Feb 2014 A1
20140107785 Geisler Apr 2014 A1
20140114418 Landry Apr 2014 A1
20140121776 Hunt May 2014 A1
20140142707 Compton et al. May 2014 A1
20140172111 Lang et al. Jun 2014 A1
20140195005 McKay Jul 2014 A1
20140228956 Weiman Aug 2014 A1
20140228960 Forterre Aug 2014 A1
20140243980 Sack et al. Aug 2014 A1
20140249631 Weiman Sep 2014 A1
20140277457 Yeung et al. Sep 2014 A1
20140277464 Richter et al. Sep 2014 A1
20140277569 Lange Sep 2014 A1
20140288649 Hunt Sep 2014 A1
20140288650 Hunt Sep 2014 A1
20140303736 Roussouly Oct 2014 A1
20140303745 Anderson et al. Oct 2014 A1
20140309743 Falahee Oct 2014 A1
20140336771 Zambiasi Nov 2014 A1
20140358246 Levy et al. Dec 2014 A1
20150045903 Neal Feb 2015 A1
20150112351 Hsu Apr 2015 A1
20150127106 Partee et al. May 2015 A1
20150173910 Siegal Jun 2015 A1
20150223951 Bae et al. Aug 2015 A1
20150282944 Guizzardi et al. Oct 2015 A1
20160015437 Elleby et al. Jan 2016 A1
20160022430 Wickham Jan 2016 A1
20160081809 Schneider Mar 2016 A1
20160166284 Hacking et al. Jun 2016 A1
20160184103 Fonte et al. Jun 2016 A1
20160193057 Rhoda Jul 2016 A1
20160206439 To et al. Jul 2016 A1
20160206440 DeRidder et al. Jul 2016 A1
20160262903 West Sep 2016 A1
20160270920 Dawson et al. Sep 2016 A1
20160287388 Hunt et al. Oct 2016 A1
20160310294 McConnell Oct 2016 A1
20160317320 Ahn Nov 2016 A1
20160324656 Morris et al. Nov 2016 A1
20160374727 Greenhalgh et al. Dec 2016 A1
20170007409 Mauldin et al. Jan 2017 A1
20170014235 Jones et al. Jan 2017 A1
20170020685 Geisler et al. Jan 2017 A1
20170042697 McShane, III Feb 2017 A1
20170049488 Vestgaarden Feb 2017 A1
20170095337 Pasini et al. Apr 2017 A1
20170095352 Bruffey Apr 2017 A1
20170100167 Lange et al. Apr 2017 A1
20170135706 Frey et al. May 2017 A1
20170135733 Donner et al. May 2017 A1
20170143383 Ingalhalikar et al. May 2017 A1
20170151005 Warren et al. Jun 2017 A1
20170156740 Stark Jun 2017 A9
20170156766 Anderson et al. Jun 2017 A1
20170156878 Tsai Jun 2017 A1
20170156879 Janowski Jun 2017 A1
20170156880 Halverson Jun 2017 A1
20170164979 Donner et al. Jun 2017 A1
20170181784 Li Jun 2017 A1
20170182222 Paddock Jun 2017 A1
20170196693 Jurick et al. Jul 2017 A1
20170216034 Daniel Aug 2017 A1
20170216035 Hunt Aug 2017 A1
20170239064 Cordaro Aug 2017 A1
20170239066 Walsh et al. Aug 2017 A1
20170258606 Afzal Sep 2017 A1
20170319353 Greenhalgh et al. Nov 2017 A1
20170348107 Lee et al. Dec 2017 A1
20170348115 Greenhalgh Dec 2017 A1
20180064540 Hunt et al. Mar 2018 A1
20180085230 Hunt Mar 2018 A1
20180110626 McShane, III Apr 2018 A1
20180161477 Nies Jun 2018 A1
20180221156 Jones Aug 2018 A1
20180243104 Garonzik Aug 2018 A1
20180256336 Mueller et al. Sep 2018 A1
20180256352 Nyahay Sep 2018 A1
20180280139 Jones Oct 2018 A1
20180289503 Knapp Oct 2018 A1
20180296343 Wei Oct 2018 A1
20180296350 Hamzey et al. Oct 2018 A1
20180326493 Gallagher et al. Nov 2018 A1
20180333272 Mirda Nov 2018 A1
20180338838 Cryder et al. Nov 2018 A1
20180368981 Mattes et al. Dec 2018 A1
20180368991 Levieux Dec 2018 A1
20190000636 Kim et al. Jan 2019 A1
20190015209 Seifert et al. Jan 2019 A1
20190038428 Stauffer Feb 2019 A1
20190060079 Unis et al. Feb 2019 A1
20190060083 Weiman et al. Feb 2019 A1
20190076266 Trudeau et al. Mar 2019 A1
20190083282 Roeder et al. Mar 2019 A1
20190091027 Asaad et al. Mar 2019 A1
20190133769 Tetsworth et al. May 2019 A1
20190151109 Arnin May 2019 A1
20190151113 Sack May 2019 A1
20190159818 Schneider et al. May 2019 A1
20190183653 Gregersen Jun 2019 A1
20190224023 Howard et al. Jul 2019 A1
20190231554 Bishop Aug 2019 A1
20190254840 Gray et al. Aug 2019 A1
20190262139 Wolters Aug 2019 A1
20190274841 Hawkes et al. Sep 2019 A1
20190298542 Kloss Oct 2019 A1
20190307574 Nyahay et al. Oct 2019 A1
20190314169 Patel et al. Oct 2019 A1
20190328546 Palagi et al. Oct 2019 A1
20190336305 Joly et al. Nov 2019 A1
20190343645 Miccio et al. Nov 2019 A1
20190358058 Trieu Nov 2019 A1
20190388238 Lechmann et al. Dec 2019 A1
20200000603 McJunkin Jan 2020 A1
20200036011 Numata et al. Jan 2020 A1
20200038197 Morris et al. Feb 2020 A1
20200038198 Miccio Feb 2020 A1
20200086625 O'Neill et al. Mar 2020 A1
20200113707 Petersheim et al. Apr 2020 A1
20200113709 Hsieh Apr 2020 A1
20200121470 Moore et al. Apr 2020 A1
20200138595 Shoshtaev et al. May 2020 A1
20200146842 Jasinski May 2020 A1
20200155326 Hunt May 2020 A1
20200179128 Stalcup et al. Jun 2020 A1
20200179133 Ryan Jun 2020 A1
20200188120 Hamzey et al. Jun 2020 A1
20200188129 McShane, III et al. Jun 2020 A1
20200188132 Ryan Jun 2020 A1
20200188133 McShane, III et al. Jun 2020 A1
20200190680 Numata et al. Jun 2020 A1
20200197189 Mazur et al. Jun 2020 A1
20200214852 Tipping et al. Jul 2020 A1
20200222201 Mirda et al. Jul 2020 A1
20200229940 Bishop et al. Jul 2020 A1
20200229945 Levieux Jul 2020 A1
20200237526 Wilson et al. Jul 2020 A1
20200246160 Zappacosta et al. Aug 2020 A1
20200261243 Unger et al. Aug 2020 A1
20200268523 Barthold et al. Aug 2020 A1
20200276019 Shetty et al. Sep 2020 A1
20200281727 Dang et al. Sep 2020 A1
20200297494 Hunt et al. Sep 2020 A1
20200297505 McLaughlin Sep 2020 A1
20200315812 Davis et al. Oct 2020 A1
20200323645 Northcutt et al. Oct 2020 A1
20200337851 Stampfli et al. Oct 2020 A1
20200337855 Stauffer et al. Oct 2020 A1
20200337856 Moore et al. Oct 2020 A1
20200345506 Ryan et al. Nov 2020 A1
20200352735 Afzal Nov 2020 A1
20200375757 Sack Dec 2020 A1
20200375758 Northcutt et al. Dec 2020 A1
20200376174 Melkent et al. Dec 2020 A1
20210046211 Deisinger et al. Feb 2021 A1
20210069383 Yamaguchi et al. Mar 2021 A1
Foreign Referenced Citations (59)
Number Date Country
101708138 May 2010 CN
103932841 Jul 2014 CN
204931903 Jan 2016 CN
19722389 Dec 1998 DE
3064175 Sep 2016 EP
3494931 Jun 2019 EP
3517078 Jul 2019 EP
3603580 Feb 2020 EP
2815846 May 2002 FR
2955025 Jul 2011 FR
H05261146 Oct 1993 JP
H09503416 Sep 1997 JP
2001523129 Nov 2001 JP
20010523129 Nov 2001 JP
2004-510494 Apr 2004 JP
2006515194 May 2006 JP
2009-505686 Feb 2009 JP
2009504332 Feb 2009 JP
4313005 Aug 2009 JP
2010137069 Jun 2010 JP
201115959 Jan 2011 JP
2012-501236 Jan 2012 JP
2012501236 Jan 2012 JP
20120501236 Jan 2012 JP
5328051 Oct 2013 JP
5455020 Mar 2014 JP
2014-151209 Aug 2014 JP
2015-502192 Jan 2015 JP
2015502192 Jan 2015 JP
5684177 Mar 2015 JP
2015529150 Oct 2015 JP
A2018-516646 Jun 2018 JP
2019034071 Mar 2019 JP
2019041886 Mar 2019 JP
2019180797 Oct 2019 JP
2019201688 Nov 2019 JP
6700135 May 2020 JP
2020199326 Dec 2020 JP
2021016498 Feb 2021 JP
WO 9510248 Apr 1995 WO
WO 9848738 Nov 1998 WO
WO 9852498 Nov 1998 WO
WO 0209625 Feb 2002 WO
WO 0234168 May 2002 WO
WO 03099160 Dec 2003 WO
WO 2004084774 Oct 2004 WO
WO 2005011523 Feb 2005 WO
WO 2009051779 Mar 2006 WO
WO 2007022194 Feb 2007 WO
WO 2009051779 Apr 2009 WO
WO 2010028056 Mar 2010 WO
2010097632 Sep 2010 WO
WO 2010097632 Sep 2010 WO
WO 2013067528 May 2013 WO
2014052477 Apr 2014 WO
2014168631 Oct 2014 WO
WO 2016044739 Mar 2016 WO
WO 2016176496 Nov 2016 WO
WO 2017100366 Jun 2017 WO
Non-Patent Literature Citations (40)
Entry
Office Action dateded May 5, 2017 in U.S. Appl. No. 15/141,655.
Office Action dated Nov. 1, 2018 in U.S. Appl. No. 15/885,418.
Final Office Action dated Feb. 25, 2019 in U.S. Appl. No. 15/885,418.
Office Action dated Nov. 2, 2021 in U.S. Appl. No. 16/593,101.
International Search Report and Written Opinion dated Aug. 19, 2016 in PCT/US2016/029865.
Office Action dated Apr. 3, 2019 in Chinese Application No. 2016800391036.
Office Action dated Jun. 28, 2019 in European Application No. 16722008.6-1132.
Extended European Search Report dated Dec. 8, 2020 in European Application No. 20191843.0-1132.
ISO/ASTM 52900:2015€ Standard Terminology for Additive Manufacturing—General Principles—Terminology, 2017, 2017.
Office Action dated Mar. 5, 2020 in Japanese Application No. 2017-556733.
Office Action dated Sep. 2, 2021 in Japanese Application No. 2020-156918.
Notice of Decision to Grant a Patent dated Jul. 7, 2022 in Japanese Application No. 2020-156918.
Office Action dated Sep. 2, 2021 in Japanese Application No. 2020-156917.
Notice of Decision to Grant a Patent dated Jul. 7, 2022 in Japanese Application No. 2020-156917.
Office Action dated May 2, 2018 in U.S. Appl. No. 15/334,053.
Office Action dated Dec. 3, 2018 in U.S. Appl. No. 15/334,053.
Office Action dated Sep. 15, 2022 in U.S. Appl. No. 16/700,632.
Final Office Action dated Jun. 2, 2023 in U.S. Appl. No. 16/700,632.
International Search Report and Written Opinion dated Jan. 18, 2018.
“FDA Clears Camber Spine Technologies' 3D Printed SPIRA Open Matrix ALIF”, Orthopedic Design & Technology, Aug. 15, 2017, Aug. 2017.
Supplemental Partial European Search Report dated May 15, 2020 in European Application No. 17866284.
Office Action dated Sep. 3, 2020 in European Application No. 17866284.
Office Action dated Mar. 23, 2022 in Chinese Application No. 2017800805197.
Office Action dated Mar. 25, 2021 in Japanese Application No. 2019-543187.
Office Action dated Aug. 5, 2021 in Japanese Application No. 2019-543187.
Office Action dated Jan. 12, 2022 in Japanese Application No. 2019-543187.
Preliminary Office Action dated Jan. 24, 2022 in Brazilian Application No. 112019008325-1.
Office Action dated Feb. 16, 2023 in Japanese Application No. 2021-197842.
Office Action dated Jul. 8, 2019 in U.S. Appl. No. 15/884,845.
Final Office Action dated Oct. 24, 2019 in U.S. Appl. No. 15/884,845.
International Search Report and Written Opinion dated Apr. 26, 2019 in PCT/US19/15946.
Office Action dated Dec. 9, 2021 in Japanese Application No. 2020-540800.
Office Action dated Nov. 5, 2020 in Australian Application No. 2019214987.
Office Action dated Oct. 15, 2021 in Australian Application No. 2019214987.
Office Action dated Oct. 25, 2018 in U.S. Appl. No. 15/791,279.
Final Office Action dated Mar. 1, 2019 in U.S. Appl. No. 15/791,279.
Office Action dated Mar. 1, 2022 in U.S. Appl. No. 16/659,011.
Final Office Action dated Jun. 21, 2022 in U.S. Appl. No. 16/659,011.
Office Action dated Feb. 27, 2023 in U.S. Appl. No. 16/659,011.
Office Action dated Apr. 20, 2023 in JP Application No. 2022-124717.
Related Publications (1)
Number Date Country
20200375757 A1 Dec 2020 US
Continuations (1)
Number Date Country
Parent 15820125 Nov 2017 US
Child 16995192 US